AlveoGene Analysis: $3M Raised
What is AlveoGene?
Inhaled gene therapy for rare respiratory diseases
Location
Oxford, United Kingdom
Employees
1-10
Founded
2022
Product Features & Capabilities
- Inhaled gene therapy solutions for rare respiratory diseases
